MI SB1349

Establishes pharmaceutical-grade cannabis as a Schedule 2 controlled substance with specific purity standards for microbial content, mycotoxins, and heavy metals for medical use by eligible patients.

Creates a licensing system for pharmaceutical-grade cannabis facilities to cultivate, manufacture, and test cannabis, with annual inspections and criminal penalties for unlicensed operations.

Implements an enhanced pharmaceutical-grade cannabis registration card system for eligible patients with debilitating medical conditions, requiring physician certification and renewal every 8 months.

Prohibits direct sales to public and smoking of pharmaceutical-grade cannabis in schools, correctional facilities, and public transportation; restricts use while operating vehicles or aircraft.

Establishes a pharmaceutical-grade cannabis fund from licensing fees, with department authority to suspend or revoke facility licenses for violations, and protects eligible patients from employment discrimination.